Williams Lewis T 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Jun 12, 2019
Insider Transaction Report
Form 4
Williams Lewis T
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2019-06-10+15,000→ 15,000 totalExercise: $6.09Exp: 2029-06-09→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]This option will vest in its entirety on the earlier to occur of (i) June 10, 2020 or (ii) the day before the 2020 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date.